Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Relation and healthcare investment firm Deerfield Management, a current investor, today announced the establishment of a new research collaboration to advance ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Akums Drugs & Pharma and Sharda University signed an MoU to collaborate on pharma research, technology transfer, skill ...

Rhapsogen, an immunology company redefining the treatment paradigm for autoimmune diseases, today announced the appointment of Renato Skerlj, Ph.D., as the company's new Chief Executive Officer, ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Headquartered in Westworks, White City Place, London, UK. Investors include Netherton Investments (a fund investing on behalf of Mike Platt) and Dompé farmaceutici S.P.A. For more information, visit ...

IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 09:00 Hrs [IST] The Indian Pharmacop ...

Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...

Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of treating two disparate conditions, one of which is the target of Merck’s fast ...

MONMOUTH JUNCTION, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced the acceptance of its peer-reviewed article "The ...

“We are pleased to welcome Behzad and Karen to 3T Biosciences at a pivotal stage for the company,” said Stefan Scherer, M.D., ...